0001179110-18-006506.txt : 20180510
0001179110-18-006506.hdr.sgml : 20180510
20180510093829
ACCESSION NUMBER: 0001179110-18-006506
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180501
FILED AS OF DATE: 20180510
DATE AS OF CHANGE: 20180510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Busse Falko
CENTRAL INDEX KEY: 0001739999
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 18820821
MAIL ADDRESS:
STREET 1: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
3
1
edgar.xml
FORM 3 -
X0206
3
2018-05-01
0
0001109354
BRUKER CORP
BRKR
0001739999
Busse Falko
40 MANNING ROAD
BILLERICA
MA
01821
0
1
0
0
President, BioSpin Group
Common Stock
7239
D
Stock option - right to buy
19.82
2025-08-07
Common Stock
12000
D
Stock option - right to buy
22.19
2026-10-04
Common Stock
7097
D
The total shares reported include (a) 557 shares of common stock; (b) 1,672 shares that are represented by restricted stock units which vest in three approximately equal annual installments on each of 10/4/2018, 10/4/2019 and 10/4/2020; and (c) 5,010 shares that are represented by restricted stock units which vest in four approximately equal annual installments on each of 8/10/2018, 8/10/2019, 8/10/2020 and 8/10/2021.
The option award became exercisable as to 3,012 shares on each of 8/7/2016 and 8/7/2017, of which options to purchase 5,975 shares are outstanding and exercisable as of 5/1/2018. The remaining options vest in two approximately equal installments on each of 8/7/2018 and 8/7/2019.
Options to purchase 1,774 shares vested on 10/4/2017 and are currently exercisable. The remaining options vest in three approximately equal installments on each of 10/4/2018, 10/4/2019 and 10/4/2020.
/s/ Michael Rich, Attorney-in-Fact
2018-05-10
EX-24
2
ex24busse.txt
Exhibit 24
POWER OF ATTORNEY
Know all by these present that the undersigned
hereby constitutes and appoints each of Michael Rich
and Tammy Fernandez of Bruker Corporation, signing
singly, the undersigned's true and lawful attorney-in-fact
to:
(1) execute for and on behalf of the
undersigned, in the undersigned's capacity as an officer
and/or director of Bruker Corporation (the "Company"), \
Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary or desirable
to complete and execute any such Form 3, 4 or 5, complete
and execute any amendment or amendments thereto, and timely
file such form with the United States Securities and
Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any type whatsoever
in connection with the foregoing which, in the opinion of
such attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it
being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-
in-fact full power and authority to do and perform any and
every act and thing whatsoever requisite, necessary, or
proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-
fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming,
any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required to
file Forms 3, 4 and 5 with respect to the undersigned's
holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 3rd day of May, 2018.
/s/Falko Busse WITNESS: /s/Helen A. Carpio
May 3, 2018